Bristol-Myers Squibb CEO: We are conducting important studies with Nektar

Giovanni Caforio, Bristol-Myers Squibb chairman and CEO, talks about the company's partnership with Nektar and latest immunotherapy treatments.
03:51
Mon, Jun 4 20188:15 AM EST